USleep ApS

 

Quicksearch
from your own companies




Analyst: XBRLDenmark
Loading...

Loading...

Loading...

Loading...

Loading...

Loading...

Loading...

Bankruptcy Risk 
2017
2017/12
2018
2018/12
2019
2019/12
2020
2020/12
2021
2021/12
Bankruptcy risk for industry  1.5% 1.5% 1.5% 1.5% 1.5%  
Bankruptcy risk  11.3% 15.3% 11.2% 18.8% 20.3%  
Credit score (0-100)  23 14 23 7 5  
Credit rating  BB BB BB B B  
Credit limit (kDKK)  0.0 0.0 0.0 0.0 0.0  

How are these values calculated?
 
View the automatically generated explanation of bankruptcy risk

Income statement (kDKK) 
2017
2017/12
2018
2018/12
2019
2019/12
2020
2020/12
2021
2021/12

Net sales  25 18 18 7 10  
Gross profit  3.7 11.6 10.0 -3.8 -0.3  
EBITDA  3.7 11.6 10.0 -3.8 -0.3  
EBIT  3.7 11.6 10.0 -3.8 -0.3  
Pre-tax profit (PTP)  3.7 11.6 10.0 -3.8 -1.2  
Net earnings  2.8 9.0 7.8 -3.0 -0.9  
Pre-tax profit without non-rec. items  3.7 11.6 10.0 -3.8 -1.2  

 
See the entire income statement

Balance sheet (kDKK) 
2017
2017/12
2018
2018/12
2019
2019/12
2020
2020/12
2021
2021/12

Tangible assets total  0.0 0.0 0.0 0.0 0.0  
Shareholders equity total  77.7 86.7 94.7 91.7 90.7  
Interest-bearing liabilities  0.0 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  78.5 90.3 96.0 91.7 91.1  

Net Debt  -78.5 -90.3 -96.0 -88.8 -87.9  
 
See the entire balance sheet

Volume 
2017
2017/12
2018
2018/12
2019
2019/12
2020
2020/12
2021
2021/12

Net sales  25 18 18 7 10  
Net sales growth  -48.8% -26.8% 0.0% -60.0% 33.3%  
Gross profit  3.7 11.6 10.0 -3.8 -0.3  
Gross profit growth  -88.0% 213.3% -13.4% 0.0% 91.3%  
Employees  0 0 0 0 0  
Employee growth %  0.0% 0.0% 0.0% 0.0% 0.0%  
Employee expenses  0.0 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  78 90 96 92 91  
Balance sheet change%  -11.6% 15.1% 6.4% -4.6% -0.6%  
Added value  3.7 11.6 10.0 -3.8 -0.3  
Added value %  15.0% 64.2% 55.6% -53.4% -3.5%  
Investments  0 0 0 0 0  

Net sales trend  -1.0 -2.0 0.0 -1.0 1.0  
EBIT trend  2.0 3.0 4.0 -1.0 -2.0  

Profitability 
2017
2017/12
2018
2018/12
2019
2019/12
2020
2020/12
2021
2021/12
EBITDA %  15.0% 64.2% 55.6% -53.4% -3.5%  
EBIT %  15.0% 64.2% 55.6% -53.4% -3.5%  
EBIT to gross profit (%)  100.0% 100.0% 100.0% 100.0% 100.0%  
Net Earnings %  11.5% 50.1% 43.5% -41.9% -9.7%  
Profit before depreciation and extraordinary items %  11.5% 50.1% 43.5% -41.9% -9.7%  
Pre tax profit less extraordinaries %  15.0% 64.2% 55.6% -53.4% -12.4%  
ROA %  4.4% 13.7% 10.7% -4.1% -0.4%  
ROI %  4.9% 14.1% 11.0% -4.1% -0.4%  
ROE %  3.7% 11.0% 8.6% -3.2% -1.0%  

Solidity 
2017
2017/12
2018
2018/12
2019
2019/12
2020
2020/12
2021
2021/12
Equity ratio %  99.0% 96.0% 98.6% 100.0% 99.6%  
Relative indebtedness %  3.3% 20.1% 7.6% 0.0% 3.9%  
Relative net indebtedness %  -315.8% -481.6% -526.0% -1,233.0% -911.2%  
Net int. bear. debt to EBITDA, %  -2,127.3% -781.3% -959.4% 2,309.4% 26,146.1%  
Gearing %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net interest  0 0 0 0 0  
Financing costs %  0.0% 0.0% 0.0% 0.0% 0.0%  

Liquidity 
2017
2017/12
2018
2018/12
2019
2019/12
2020
2020/12
2021
2021/12
Quick Ratio  96.0 25.0 70.1 0.0 244.9  
Current Ratio  96.0 25.0 70.1 0.0 244.9  
Cash and cash equivalent  78.5 90.3 96.0 88.8 87.9  

Capital use efficiency 
2017
2017/12
2018
2018/12
2019
2019/12
2020
2020/12
2021
2021/12
Trade debtors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Trade creditors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Current assets / Net sales %  319.1% 501.7% 533.6% 1,273.1% 949.0%  
Net working capital  77.7 86.7 94.7 91.7 90.7  
Net working capital %  315.8% 481.6% 526.0% 1,273.1% 945.1%  

Employee efficiency 
2017
2017/12
2018
2018/12
2019
2019/12
2020
2020/12
2021
2021/12
Net sales / employee  0 0 0 0 0  
Added value / employee  0 0 0 0 0  
Employee expenses / employee  0 0 0 0 0  
EBITDA / employee  0 0 0 0 0  
EBIT / employee  0 0 0 0 0  
Net earnings / employee  0 0 0 0 0